A detailed examination of pre-treatment tumor sections demonstrated rare infiltration of CD8<sup>+</sup> T cells, indicating that the current patient presented with an "immune-cold" microenvironment, which might explain the primary resistance to chemo-immunotherapy. This evidence concerns the gene CD8A and neoplasm.